Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the threat of drug import duties from the Trump administration.
The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...
US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback